Researchers at the University of Malta have found a possible reason for the ongoing and often debilitating symptoms experienced by long COVID-19 patients.
The ASTAR Infectious Diseases Labs (ASTAR ID Labs) and the National Centre for Infectious Diseases (NCID) researchers have published a study in the Journal of Medical Virology, that shows that the extended inflammation observed in COVID-19 patients who were hospitalized is reduced to healthy levels within two years of the first infection.
The University of Queensland researchers found that viruses such as SARS-CoV-2 can cause brain cells to fuse, leading to chronic neurological symptoms.
A team of researchers from Baidu Research recently developed an AI algorithm that can quickly design highly stable COVID-19 mRNA vaccine sequences, even when they were previously unattainable. The algorithm, called LinearDesign, represents a significant breakthrough in both stability and efficacy for vaccine sequences, achieving a 128-fold increase in the COVID-19 vaccine’s antibody response.
The COVID-19 pandemic has killed around 7 million people worldwide (1.1 million in the United States) and made many more people sick. Vaccines and antiviral treatments helped save many lives and reduce sickness.
Recently, a team of Japanese researchers has identified the SARS-CoV-2 Omicron XBB.1.5 variant prevalent in the Western hemisphere, which has high transmissibility and infectivity, and is a cause of concern for public health.
During the pandemic, medical doctors and researchers noticed that children and adolescents infected with COVID-19 became less ill than adults. A possible explanation for this is that children already had a prior level of immunity to COVID-19 provided by memory T cells generated by common colds.
According to the Journal of the American Medical Association, child and adolescent mortality rates in the United States have increased by 20%, the largest increase in at least 50 years.
A new study shows that people who previously had COVID-19 have an 88% lower risk of being hospitalized or dying compared to those who have never been infected.
The study shows that the risk of developing Type 2 diabetes after a COVID-19 infection is not just an early observation but is, in fact, a real risk that has persisted through the Omicron era.